Balanced news tone
News Sentiment
PSNL sentiment intelligence
Personalis Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+3.3% over one week, +46.7% over four weeks, trend active, and materially above fair value.
Personalis (PSNL) Recovers After Sale Speculation
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Form 4 Personalis Inc For: 26 June By Investing.com
This article announces the filing of Form 4 for Personalis Inc. for the date of June 26. It is a brief, procedural post from Investing.com, indicating routine financial reporting for the company.
- Tone
- Positive 60/100
- Event
- Market update
- Published
- 27 Jun 2026 03:40
- Source
- Investing.com Nigeria
Personalis (PSNL) CFO uses 10b5-1 plan to exercise options and sell shares
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Stock Titan
Personalis’ CE-IVD Win Raises Questions On MRD Traction In Europe
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- simplywall.st
Personalis Gains EU Approval for Blood Collection Kits Used in Genomic Testing
- Tone
- Positive 58/100
- Event
- Regulatory and legal
- Published
- 09 Jun 2026 11:09
- Source
- MT Newswires
Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 10:00
- Source
- Business Wire
Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 14:51
- Source
- Motley Fool
Personalis' Cancer Monitoring Tool Shows Early Detection of Relapse
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 12:03
- Source
- MT Newswires
Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 10:00
- Source
- Business Wire
Assessing Personalis (PSNL) Valuation After Its Strong Recent Share Price Momentum
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Market source
Personalis: Initiating Coverage Of Cancer Testing Biotech With A Buy Rating (NASDAQ:PSNL)
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 28 May 2026 07:00
- Source
- Seeking Alpha
Deep Track (PSNL) discloses 5.51% holding in Personalis as of May 12, 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Stock Titan
Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
How The Personalis (PSNL) Story Is Shifting With Cautious Targets And Execution Risks
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Market source
Personalis stock rises after Medicare approves lung cancer test coverage By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Feb 2026 15:29
- Source
- Investing.com Nigeria
Personalis, Inc. (PSNL): A Bull Case Theory
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Feb 2026 08:00
- Source
- Market source
Personalis, Inc. (NASDAQ:PSNL) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jan 2026 08:00
- Source
- simplywall.st
Is Personalis (NASDAQ:PSNL) A Risky Investment?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Sep 2025 07:00
- Source
- simplywall.st